Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
about
Cost-Effectiveness and Cost Thresholds of Generic and Brand Drugs in a National Chronic Hepatitis B Treatment Program in ChinaCurrent hepatitis B treatment guidelines and future research directions.Prognostic values of fluctuations in serum levels of alanine transaminase in inactive carrier state of HBV infection.Generation of covalently closed circular DNA of hepatitis B viruses via intracellular recycling is regulated in a virus specific manner.Cost-effectiveness analysis of a hepatitis B vaccination catch-up program among children in Shandong Province, ChinaCharacteristics of chronic hepatitis B patients who underwent liver biopsies.AASLD guidelines for treatment of chronic hepatitis B.Longitudinal change of HBsAg in HBeAg-negative patients with genotype B or C infection.Postpartum care for mothers diagnosed with hepatitis B during pregnancy.Assessment of noninvasive liver stiffness in inactive HBsAg carriers by transient elastography: Fibroscan in inactive HBsAg carriers.The HBV DNA cutoff value for discriminating patients with HBeAgnegative chronic hepatitis B from inactive carriers.Globulin-platelet model predicts minimal fibrosis and cirrhosis in chronic hepatitis B virus infected patientsRates and risk factors for hepatitis B reactivation in a cohort of persons in the inactive phase of chronic hepatitis B-Alaska, 2001-2010.Hepatitis B surface antigen clearance in inactive hepatitis B surface antigen carriers treated with peginterferon alfa-2aDisease burden of chronic hepatitis B among immigrants in Canada.Parameters associated with significant liver histological changes in patients with chronic hepatitis B.Inactıve hepatitis B surface antigen carriers and intrafamilial tramsmission: results of a 10-year study.The prognosis and management of inactive HBV carriers.Screening and diagnosis of HBV in low-income and middle-income countries.Viral level is an indicator of long-term outcome of hepatitis B virus e antigen-negative carriers with persistently normal serum alanine aminotransferase levels.The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.Population health impact and cost-effectiveness of monitoring inactive chronic hepatitis B and treating eligible patients in Shanghai, China.Genetic variation in interleukin 28B and correlation with chronic hepatitis B virus infection in Saudi Arabian patients.Association of a potential functional pre-miR-218 polymorphism and its interaction with hepatitis B virus mutations with hepatocellular carcinoma risk.Viral load, genotypes, and mutants in hepatitis B virus-related hepatocellular carcinoma: special emphasis on patients with early hepatocellular carcinoma.Clinical use of liver biopsy for the diagnosis and management of inactive and asymptomatic hepatitis B virus carriers in Bangladesh.Meta-analysis: oral anti-viral agents in adults with decompensated hepatitis B virus cirrhosis.Cost effectiveness of screening immigrants for hepatitis B.Host genetic variants and hepatitis B virologic features in HBeAg-negative hepatitis B carriers with long-term biochemical remission.Biochemical, virological, immunological and histopathological features of 702 incidentally detected chronic hepatitis B virus carriers in Bangladesh.Serum hepatitis B virus-DNA levels correlate with long-term adverse outcomes in spontaneous hepatitis B e antigen seroconverters.Viral Hepatitis Strategic Information to Achieve Elimination by 2030: Key Elements for HIV Program Managers.Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion.Predictive value of HBsAg quantification for determining the clinical course of genotype C HBeAg-negative carriers.
P2860
Q28550643-489CA4ED-0FC0-4511-83FB-026480D01BFAQ30487002-F75D6CB0-0F48-4A0F-A3E3-0D585B92ACA2Q33580037-22D11ED6-C7B8-44C6-A5CC-2D8C349D98C7Q33686965-AF7BFA5A-D6DF-4C8C-AAE3-4E07B1082916Q33723491-34CCA126-B6E6-45FA-B7EA-0CD5A9059E54Q34414362-C88CA895-3D99-4195-81E4-40E36AB0723CQ34501660-363A04FC-1866-44A3-8C5E-BFE8E71FA823Q34598267-F5D87149-7E8F-49E7-8F92-3FD59FB545C7Q35137366-C9B372C1-5FB2-4514-8AFF-ABDCCA7E62DEQ35507606-5E954F2D-9B46-4AB8-A373-2475C48405EBQ35540247-A0366FE4-1A05-429B-B0D3-C5FA47C8A999Q36031303-51299A68-FE7B-4BB3-A98E-F148BE22DB80Q36177134-BCF430E1-0864-4D10-902A-3915A126B620Q36924978-364059AB-13CA-4D39-A1B3-A8C57804E631Q37066397-03797EB5-D147-4554-99F7-F5C1A1D27A85Q37590449-3716875B-4176-46B4-A6C3-B478EF514E1EQ37711325-AAD2309C-BDB3-4B7B-89D1-BB5D674C91EDQ38685595-31F7EEC0-7138-4520-A2D1-DAB69E8D9B98Q38953790-F06967D4-B09E-4F08-820D-335256B3BD57Q39737072-CF7C6D83-C41F-4A68-821C-A37BEBA1B702Q40699496-461F0028-4BD1-40A3-BB95-64BC4045208BQ42208578-593B1228-9D5A-4293-8EAD-DB83DDD19B50Q42263068-2120A984-681D-4D27-A580-35AEB5B87555Q42263074-0CBBB654-A285-42F7-951F-4D71549F82AFQ42492943-34305B31-1E73-4632-A1EA-2436C6C7DB6EQ43008095-1740DD00-F1C6-4731-A73F-D27ED95CBB98Q43493641-72252668-02CF-436E-89F1-DFA6FE4EAC8EQ44428905-E5472E70-AF02-470F-9AF6-71C61F0E4D21Q45020360-8A6CDCFE-9EE8-4843-8566-B7FF9E48E9D6Q45356980-BEF4CF20-427C-4B11-861B-27728BD0143FQ45361615-C786887E-DE92-455E-90A8-A28E1A8A627BQ47300268-6B2CD9D4-B839-4E22-8E37-08B002688502Q51368668-0A41F370-E8D3-471E-ACB4-A93D6B573D10Q53396130-7E8CC928-4993-4A99-B6A5-68258D1081E1
P2860
Incidence and risk factors of progression to cirrhosis in inactive carriers of hepatitis B virus.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Incidence and risk factors of ...... carriers of hepatitis B virus.
@en
Incidence and risk factors of ...... carriers of hepatitis B virus.
@nl
type
label
Incidence and risk factors of ...... carriers of hepatitis B virus.
@en
Incidence and risk factors of ...... carriers of hepatitis B virus.
@nl
prefLabel
Incidence and risk factors of ...... carriers of hepatitis B virus.
@en
Incidence and risk factors of ...... carriers of hepatitis B virus.
@nl
P2860
P356
P1476
Incidence and risk factors of ...... carriers of hepatitis B virus.
@en
P2093
Chia-Ming Chu
P2860
P2888
P304
P356
10.1038/AJG.2009.187
P407
P50
P577
2009-05-19T00:00:00Z
P5875
P6179
1023009919